Registration - In-house Organization

Novo Nordisk Canada Inc. / Vince Lamanna, President

Registration Information

In-house Organization name: Novo Nordisk Canada Inc.
Responsible Officer Name: Vince Lamanna, President
Responsible Officer Change History
Initial registration start date: 2017-09-13
Registration status: Active
Registration Number: 954988-360616

Associated Communications

Total Number of Communication Reports: 77

Monthly communication reports in the last 6 months: 3

Version 11 of 16 (2022-03-10 to 2022-09-16)

Registration versions:

Version 11 of 16 (2022-03-10 to 2022-09-16)

Lobbying Information

Subject Matters

Aboriginal Affairs
Arts and Culture
Budget
Economic Development
Employment and Training
Health
Industry
Intellectual Property
Internal Trade
International Development
International Relations
International Trade
Regional Development
Research and Development
Science and Technology

Subject Matter Details

Policies or Program

Advocate for the implementation of a federal diabetes and obesity strategy.
Commemoration of the 100th anniversary of the discovery of insulin in Canada.
Support the establishment of a life sciences strategy in Canada

Policies or Program, Regulation

Impact of Patented Medicine Prices Review Board reform on the life sciences sector.

Communication Techniques

Written communication
Oral communication

Government Institutions

Canada Foundation for Innovation
Canadian Heritage (PCH)
Canadian Human Rights Tribunal (CHRT)
Canadian Institutes of Health Research (CIHR)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
NAFTA Secretariat
National Research Council (NRC)
Parks Canada (PC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Senate of Canada
Treasury Board Of Canada Secretariat (TBS)

In-house Organization Details

Description of the organization's activities

At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity.

Responsible officer name and position during the period of this registration

Béatrice Clerc, President

Organization's membership or classes of membership

Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 80 countries and markets its products in 170 countries.

Government funding

No government funding was received during the last completed financial year.

In-house Organization Contact Information

Address:
101-2476 Argentia Road
Mississauga, ON L5N 6M1
Canada

Telephone number: 905-629-4222

Lobbyists Details

Employees who lobby for the organization

Gabrielle Berard, Senior Manager, External Affairs | Designated public offices held
Michael Tucker, Patient Access Manager, Atlantic | No public offices held

Novo Nordisk Canada Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Novo Nordisk Canada Inc./	2017-09-13	current

Novo Nordisk Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Vince Lamanna	2023-06-01	Current
Béatrice Clerc	2019-09-19	2023-06-01
Brian Hilberdink	2017-09-13	2019-09-17

Vince Lamanna, President (Organization)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-77 of 77

Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Luc Theriault, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2023-11-07
Posted date: 2023-11-15
Communication number: 360616-584068 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Chelsea Madryga, Policy Advisor | Office of the Minister of Health | Health Canada (HC)
- Eshan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-10-13
Posted date: 2023-11-15
Communication number: 360616-579538 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Danna Campbell, Director, Partnerships & Strategies | Health Promotion and Chronic Disease Prevention Branch | Health Canada (HC)
- David Luchuk, A/Director | Health Promotion and Chronic Disease Prevention Branch, Centre for Chronic Disease Prevention and Health Equity, Policy and Engagement Division | Public Health Agency of Canada (PHAC)
- Michael Collins, A/Vice-President | Health Promotion and Chronic Disease Prevention Branch | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2023-09-19
Posted date: 2023-10-16
Communication number: 360616-577177 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Stephen Ellis, Member of Parliament, Cumberland-Colchester | House of Commons
Subject Matter of the communication: Health
Communication date: 2023-05-29
Posted date: 2023-06-15
Communication number: 360616-566944 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Benoit Leduc, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health
Communication date: 2023-05-04
Posted date: 2023-06-15
Communication number: 360616-564219 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Eric Belair, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
- Stephen Lucas, Deputy Minister | Health Canada (HC)
- Michael Collins, A/ Associate Deputy Minister | Health Promotion and Chronic Disease Prevention Branch | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2023-05-03
Posted date: 2023-06-15
Communication number: 360616-564217 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Sandenga Yeba, Deputy Director of Policy | Minister's Office | Health Canada (HC)
- Jamie Kippen, Chief of Staff | Office of the Minister | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-04-12
Posted date: 2023-05-15
Communication number: 360616-561897 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Razan Shahin, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Caroline Menard, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development
Communication date: 2023-03-29
Posted date: 2023-04-15
Communication number: 360616-560744 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Sarah MacDonald, Special Assistant (Assistant to the Parliamentary Secretary and Parliamentary Affairs) | Innovation, Science and Economic Development Canada (ISED)
- Andy Fillmore, Parliamentary Secretary to the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development
Communication date: 2023-03-27
Posted date: 2023-04-15
Communication number: 360616-560640 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Chelsea Madryga, Parliamentary Secretary Assistant | Health Canada (HC)
- Adam van Koeverden , Parliamentary Secretary | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-03-21
Posted date: 2023-04-15
Communication number: 360616-560456 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Policy Advisor | Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health
Communication date: 2023-03-06
Posted date: 2023-04-15
Communication number: 360616-557753 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Caroline Menard, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health
Communication date: 2023-02-16
Posted date: 2023-03-15
Communication number: 360616-557037 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Poppy Vineberg, Director | Strategic Horizontal Social Policy | Employment and Social Development Canada (ESDC)
- Marebame Longe, Manager | Strategic Policy | Employment and Social Development Canada (ESDC)
- Kaitlin Blackhall, Manager | Strategic Policy | Employment and Social Development Canada (ESDC)
- Erin Krzyzanowski, Manager | Social Development Policy | Employment and Social Development Canada (ESDC)
- An Brian A Huynh, Junior Policy Analyst | Social Development Policy | Employment and Social Development Canada (ESDC)
- Jason Baillargeon, Director | Food Policy Division | Agriculture and Agri-Food Canada (AAFC)
- Patrick Verreault, Deputy Director | Food Policy Division | Agriculture and Agri-Food Canada (AAFC)
Subject Matter of the communication: Health
Communication date: 2023-02-10
Posted date: 2023-02-15
Communication number: 360616-556448 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Adam van Koeverden, , Parliamentary Secretary to the Minister of Health and to the Minister of Sport | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-12-13
Posted date: 2022-12-15
Communication number: 360616-551769 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- David Luchuk, Manager | Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
- Annie Comtois, Acting Executive Director | EXECUTIVE DIRECTOR OFFICE BUREAU DE LA DIRECTRICE EXÉCUTIVE EDO-BDE | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2022-11-25
Posted date: 2022-12-15
Communication number: 360616-551750 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Tasha Stefanis, Associate Vice President | Health Promotion and Chronic Disease Prevention | Public Health Agency of Canada (PHAC)
- Pamela Turpin, Manager | Public Health Agency of Canada (PHAC)
- Annie Comtois, Director, Programs and Performance | Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
- Mark Nafekh, Director General, Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2022-09-26
Posted date: 2022-12-15
Communication number: 360616-551859 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Nathanielle Morin, Policy Advisor | Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-08-30
Posted date: 2022-12-15
Communication number: 360616-551874 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Mark Nafekh, Director General, Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2022-07-21
Posted date: 2022-12-15
Communication number: 360616-551851 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Patrick Delorme, Policy Analyst | PHAC | Public Health Agency of Canada (PHAC)
- Nolan D’Souza, Program/Policy Fellow | PHAC | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2022-04-25
Posted date: 2022-12-15
Communication number: 360616-551845 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Kathy Thompson, Executive Vice-President of the Public Health Agency of Canada | PHAC | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2022-04-05
Posted date: 2022-12-15
Communication number: 360616-551843 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Heather Jeffrey, Associate Deputy Minister of Health | Health Canada (HC)
- Adam Van Koeverden, Member of Parliament | Parliamentary Secretary to the Minister of Health and Sport | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-04-04
Posted date: 2022-12-15
Communication number: 360616-552263 (amended from 360616-551831) View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Stephen Ellis, Member of Parliament, Cumberland-Colchester | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-03-15
Posted date: 2022-12-15
Communication number: 360616-551788 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Michael Barrett, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-03-10
Posted date: 2022-03-10
Communication number: 360616-524796 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Lindsay Mathyssen, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-02-28
Posted date: 2022-03-09
Communication number: 360616-524604 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Carol Hughes, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-02-28
Posted date: 2022-03-09
Communication number: 360616-524599 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Nathanielle Morin, Policy Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-02-25
Posted date: 2022-03-09
Communication number: 360616-524594 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Rebecca Caldwell, Senior Policy Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2022-02-22
Posted date: 2022-03-09
Communication number: 360616-523631 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Ziad Aboultaif, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-02-15
Posted date: 2022-03-09
Communication number: 360616-523595 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Chris d'Entremont, Member of Pariament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-11-23
Posted date: 2021-12-15
Communication number: 360616-516121 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Sonia Sidhu, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-11-05
Posted date: 2021-11-16
Communication number: 360616-516015 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Marie-France Lalonde, Member of Parliament | Orléans | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2021-04-01
Posted date: 2021-05-15
Communication number: 360616-500466 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Marie-France Lalonde, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-03-22
Posted date: 2021-04-15
Communication number: 360616-500123 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Scott Aitchison, Member of Parliament | Parry Sound—Muskoka | House of Commons
Subject Matter of the communication: Health, Arts and Culture
Communication date: 2021-02-08
Posted date: 2021-03-15
Communication number: 360616-494594 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Sonia Sidhu, Member of Parliament | Brampton South | House of Commons
Subject Matter of the communication: Health, Research and Development
Communication date: 2021-01-18
Posted date: 2021-02-15
Communication number: 360616-493912 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Chris D'Entremont, Member of Parliament | West Nova | House of Commons
Subject Matter of the communication: Health, Research and Development, Arts and Culture
Communication date: 2020-10-29
Posted date: 2020-11-16
Communication number: 360616-485814 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Helena Jaczek, Member of Parliament | Markham—Stouffville | House of Commons
Subject Matter of the communication: Health, Science and Technology, Arts and Culture
Communication date: 2020-10-26
Posted date: 2020-11-16
Communication number: 360616-485816 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Ali Ehsassi, Parliamentary Secretary | Innovation and Industry | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Research and Development, Arts and Culture
Communication date: 2020-10-20
Posted date: 2020-11-16
Communication number: 360616-485585 (amended from 360616-485584) View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Judith Seidman, Senator | Senate of Canada
Subject Matter of the communication: Health, Research and Development, Arts and Culture
Communication date: 2020-10-16
Posted date: 2020-11-16
Communication number: 360616-485815 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Amanda Woodley, Special Assistant, Policy and Assistant to the Parliamentary Secretary | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Science and Technology, Arts and Culture
Communication date: 2020-09-14
Posted date: 2020-10-15
Communication number: 360616-481823 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- William Amos, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology, Industry, Arts and Culture
Communication date: 2020-09-11
Posted date: 2020-10-15
Communication number: 360616-481820 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Christine Loth-Bown, Vice-President | Indigenous Affairs and Cultural Heritage Directorate | Parks Canada (PC)
Subject Matter of the communication: Arts and Culture
Communication date: 2020-08-31
Posted date: 2021-07-14
Communication number: 360616-510412 (amended from 360616-481813) View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Sonia Sidhu, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Research and Development, Arts and Culture
Communication date: 2020-07-17
Posted date: 2020-08-15
Communication number: 360616-478477 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Janet McPhee, Senior Investment Officer | Global Affairs Canada (GAC)
- Zoe Hawa, Deputy Director, Life Sciences | Global Affairs Canada (GAC)
- Louise Rousseau, Deputy Director - Geographic (Europe) | Global Affairs Canada (GAC)
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology, Industry, Employment and Training
Communication date: 2019-02-26
Posted date: 2019-03-15
Communication number: 360616-447035 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Arthur Lam, Senior Advisor | Small Business Minister's Office and Export Promotion | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry, Internal Trade, Employment and Training
Communication date: 2019-02-26
Posted date: 2019-03-15
Communication number: 360616-447034 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Emily Yorke, Senior Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Economic Development, Health, Industry, Regional Development
Communication date: 2019-02-26
Posted date: 2019-03-15
Communication number: 360616-447030 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Gagan Sikand, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Industry
Communication date: 2019-02-20
Posted date: 2019-03-15
Communication number: 360616-447033 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Gagan Sikand, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Industry, Employment and Training
Communication date: 2019-02-11
Posted date: 2019-03-15
Communication number: 360616-447032 (amended from 360616-447031) View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Gagan Sikand, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology, Industry
Communication date: 2019-01-30
Posted date: 2019-02-15
Communication number: 360616-444411 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | LSID | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Research and Development, Industry
Communication date: 2019-01-22
Posted date: 2019-02-15
Communication number: 360616-444410 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | LSID | Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc, Manager | LSID | Innovation, Science and Economic Development Canada (ISED)
- Edward Burrows, Analyst / Economist | LSID | Innovation, Science and Economic Development Canada (ISED)
- Tereasa Chudy, Economist | LSID | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Research and Development, Industry
Communication date: 2019-01-09
Posted date: 2019-02-04
Communication number: 360616-444409 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | LSID | Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc, Sr Project Leader | LSID | Innovation, Science and Economic Development Canada (ISED)
- Jessica Godard, Junior Analyst | LSID | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology, Industry, International Development, International Trade
Communication date: 2018-12-14
Posted date: 2018-12-17
Communication number: 360616-442796 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Kevin Deagle, Policy Advisor | Indigenous Services Canada (ISC)
- Kathy Kettler, Advisor | Indigenous Services Canada (ISC)
Subject Matter of the communication: Economic Development, Health, International Relations, Regional Development, Aboriginal Affairs
Communication date: 2018-12-14
Posted date: 2018-12-17
Communication number: 360616-442795 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Gagan Sikand, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Research and Development, Regional Development, Aboriginal Affairs
Communication date: 2018-12-13
Posted date: 2018-12-17
Communication number: 360616-442793 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
- Tanya Potashnick, Director | Patented Medicine Prices Review Board (PMPRB)
- Matthew Kellison, Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry
Communication date: 2018-12-11
Posted date: 2018-12-17
Communication number: 360616-442783 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Kevin Deagle, Policy Advisor | Indigenous Services Canada (ISC)
- Joseph Wabegijig, Policy Advisor | Indigenous Services Canada (ISC)
Subject Matter of the communication: Economic Development, Health, Research and Development, Industry, Aboriginal Affairs
Communication date: 2018-11-16
Posted date: 2018-11-26
Communication number: 360616-440208 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Kate Proctor, Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development, Industry
Communication date: 2018-11-16
Posted date: 2018-11-26
Communication number: 360616-440207 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc, Sr Project Leader | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology, Industry
Communication date: 2018-11-16
Posted date: 2018-11-26
Communication number: 360616-440206 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Kate Moussouni, Senior Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Economic Development, Health, Research and Development
Communication date: 2018-11-16
Posted date: 2018-11-26
Communication number: 360616-440205 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Health Canada (HC)
- Abby Hoffman, Assistant Deputy Minister | Strategic Policy Branch (SPB) | Health Canada (HC)
- Kathryn Nowers, Director of Policy | Office of the Minister | Health Canada (HC)
- John Knubley, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Paul Halucha, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Intellectual Property, Science and Technology, Industry, Internal Trade
Communication date: 2018-10-05
Posted date: 2018-10-26
Communication number: 360616-436555 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Gabe Frost, Senior Policy Analyst | Regulatory Review | Treasury Board Of Canada Secretariat (TBS)
- Rob Turk, Policy Advisor | Food and Agriculture Regulatory Reviews | Treasury Board Of Canada Secretariat (TBS)
- Christopher Lee, Research Analyst | Regulatory Reviews | Treasury Board Of Canada Secretariat (TBS)
- Alan Neeff, Director | Regulatory Policy Cooperation | Treasury Board Of Canada Secretariat (TBS)
- Alexandra Nur, Senior Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
- Barn-Yen Li, Senior Advisor | Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development
Communication date: 2018-08-29
Posted date: 2018-09-07
Communication number: 360616-433231 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development, Science and Technology
Communication date: 2018-08-29
Posted date: 2018-09-07
Communication number: 360616-433230 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- John Oliver, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development
Communication date: 2018-08-27
Posted date: 2018-09-07
Communication number: 360616-433227 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Maximilien Roy, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development, Science and Technology
Communication date: 2018-08-09
Posted date: 2018-09-07
Communication number: 360616-433229 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc, Senior Policy Analyst | Innovation, Science and Economic Development Canada (ISED)
- Razan Shahin, Sector Analyst | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development
Communication date: 2018-07-18
Posted date: 2018-09-07
Communication number: 360616-433228 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)
- Elder Marques, Senior Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development, Science and Technology
Communication date: 2018-07-12
Posted date: 2018-09-07
Communication number: 360616-433226 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Christopher Berzins, Director of Policy | Trade Minister's Office | Global Affairs Canada (GAC)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development
Communication date: 2018-07-12
Posted date: 2018-09-07
Communication number: 360616-433225 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Shawn Tupper, Assistant Secretary to Cabinet, Economic and Regional Development Policy (Operations) | Privy Council Office (PCO)
- Marian Campbell Jarvis, Assistant Secretary to the Cabinet, Social Development Policy | Privy Council Office (PCO)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development
Communication date: 2018-07-12
Posted date: 2018-09-07
Communication number: 360616-433224 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- John Oliver, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Intellectual Property
Communication date: 2018-05-08
Posted date: 2018-09-07
Communication number: 360616-433223 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Janet MacPhee, A/Director | Global Affairs Canada (GAC)
- Kim Ryel, Manager, life sciences | Global Affairs Canada (GAC)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development
Communication date: 2018-05-08
Posted date: 2018-09-07
Communication number: 360616-433222 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Sheryl Groeneweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
- Nancy Nancy Faraday-Smith, A/Director | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development
Communication date: 2018-05-08
Posted date: 2018-09-07
Communication number: 360616-433221 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | PMPRB | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development
Communication date: 2018-05-08
Posted date: 2018-09-07
Communication number: 360616-433220 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Bill Morneau, Minister of Finance | House of Commons
Subject Matter of the communication: Health
Communication date: 2018-03-01
Posted date: 2018-04-16
Communication number: 360616-420970 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Ramez Ayoub, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2018-02-20
Posted date: 2018-03-15
Communication number: 360616-420969 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Sonia Sidhu, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2018-02-15
Posted date: 2018-03-15
Communication number: 360616-420968 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- David Clemens, Manager, Business Development and Analytics | Canadian Institutes of Health Research (CIHR)
Subject Matter of the communication: Health, Research and Development
Communication date: 2017-12-05
Posted date: 2018-03-06
Communication number: 360616-420967 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Corinne Guenette, Director, Life Science Industries, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
- Shawn Tippins, Policy Analyst, Industry Sector – Life Sciences | Innovation, Science and Economic Development Canada (ISED)
- Nancy Faraday-Smith, Manager, Life Sciences Industries, Manufacturing and Life Sciences Branch, Innovation Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc, Manager, Life Sciences Industries, Manufacturing and Life Sciences Branch, Innovation Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development
Communication date: 2017-12-05
Posted date: 2018-03-06
Communication number: 360616-420966 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Pam Goldsmith Jones, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2017-12-05
Posted date: 2018-03-06
Communication number: 360616-420965 View associated registration

Vince Lamanna, President (Organization)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-77 of 77

Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Luc Theriault, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2023-11-07
Posted date: 2023-11-15
Communication number: 360616-584068 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Chelsea Madryga, Policy Advisor | Office of the Minister of Health | Health Canada (HC)
- Eshan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-10-13
Posted date: 2023-11-15
Communication number: 360616-579538 View associated registration
Novo Nordisk Canada Inc.
In-house Organization

Designated Public Office Holders who participated in the communication:
- Danna Campbell, Director, Partnerships & Strategies | Health Promotion and Chronic Disease Prevention Branch | Health Canada (HC)
- David Luchuk, A/Director | Health Promotion and Chronic Disease Prevention Branch, Centre for Chronic Disease Prevention and Health Equity, Policy and Engagement Division | Public Health Agency of Canada (PHAC)
- Michael Collins, A/Vice-President | Health Promotion and Chronic Disease Prevention Branch | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2023-09-19
Posted date: 2023-10-16
Communication number: 360616-577177 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Director of Parliamentary Affairs Parliament of Canada, Senate of Canada	August 2017 to August 2018	Not a designated office
Policy Advisor Finance Canada, Office of the Minister of Finance	October 2011 to November 2014	November 21, 2014

Date Modified:: 2023-11-27

Search and menus

Language selection

Registration - In-house Organization

Novo Nordisk Canada Inc. / Vince Lamanna, President

Registration Information

Associated Communications

Version 11 of 16 (2022-03-10 to 2022-09-16)

Version 11 of 16 (2022-03-10 to 2022-09-16)

Subject Matters

Subject Matter Details

Policies or Program

Policies or Program, Regulation

Communication Techniques

Government Institutions

Description of the organization's activities

Responsible officer name and position during the period of this registration

Organization's membership or classes of membership

Government funding

In-house Organization Contact Information

Employees who lobby for the organization